Breaking News, Promotions & Moves

Vital Therapies Expands Executive Team

Swanson, Henry, Loewen, and Murawski take on financial, clinical, regulatory, and manufacturing roles

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Michael Swanson has been appointed chief financial officer and treasurer of Vital Therapies, Inc. (VTI). He has more than 20 years of experience in senior financial positions in public and private life sciences companies. Mr. Swanson has served as chief financial officer at Amira Pharmaceuticals, Prometheus Labs, and Advanced Tissue Sciences. He also served as director of finance of the Fisher Scientific Group, and its parent, The Henley Group.       Andrew Henry has been named vice president of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters